EagleClaw Capital Managment, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1607636 BOSTON, MA

Position in CRSP

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$929,907

New position

Shares Held

17,050

first reported quarter

Ownership

0.018%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#176

of 519 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $4,783,467 across 3 Biotechnology names. CRSP ranks #2 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	7,535	$3,742,860
2	CRSP	CRISPR Therapeutics AG This page	17,050	$929,907
3	REPL	Replimune Group, Inc.	10,000	$110,700

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$929,907	17,050	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.